Showing 21 - 40 results of 282 for search '"hemostasis"', query time: 0.06s Refine Results
  1. 21
  2. 22
  3. 23

    A Case of Radical Resection of Esophageal Basaloid Cell Carcinoma After Hemostasis by Transarterial Embolization by Keita Sato, Koji Takahashi

    Published 2025-01-01
    “…TAE is effective for hemostasis and serves as a crucial bridge to radical esophageal tumor resection.…”
    Get full text
    Article
  4. 24
  5. 25
  6. 26

    Impact of thermal denaturation on renal volume reduction after partial nephrectomy using soft coagulation hemostasis by Ibuki Tsuru, Masashi Kusakabe, Taro Izumi, Akihiro Ono, Yasuko Muraki, Taro Teshima, Ryo Amakawa, Yasushi Inoue, Tadashi Yoshimatsu, Teppei Morikawa, Haruki Kume, Shuji Kameyama, Yoshiyuki Shiga, Masaki Nakamura

    Published 2025-01-01
    “…This study aimed to assess the impact of soft coagulation hemostasis on parenchymal volume reduction of the operated kidney after an open partial nephrectomy. …”
    Get full text
    Article
  7. 27
  8. 28
  9. 29

    Clinical role of endothelial dysfunction and hemostasis gene allelic variants in hepatitis C virus-associated cryoglobulinemia by M. V. Sokolova, Ye. Ye. Starostina, T. N. Krasnova, L. M. Samokhodskaya, T. P. Rozina, V. G. Avdeyev, M. G. Artemova, Ye. B. Yarovaya, N. A. Mukhin

    Published 2018-08-01
    “…To estimate the effect of carriage of endothelial dysfunction and hemostasis gene allelic variants on development of cryoglobulinemic vasculitis (CryoVas) and its clinical symptoms in patients with chronic hepatitis C (CHC). …”
    Get full text
    Article
  10. 30

    Timing of Rebleeding in High-Risk Peptic Ulcer Bleeding after Successful Hemostasis: A Systematic Review by Sara El Ouali, Alan N Barkun, Myriam Martel, Davide Maggio

    Published 2014-01-01
    “…BACKGROUND: Peptic ulcer rebleeding (PUR) usually occurs within three days following endoscopic hemostasis. However, recent data have increasingly suggested delayed rebleeding.…”
    Get full text
    Article
  11. 31

    Therapy with Interleukin-22 Alleviates Hepatic Injury and Hemostasis Dysregulation in Rat Model of Acute Liver Failure by Tariq Helal Ashour

    Published 2014-01-01
    “…Taken together, therapy with IL-22 can represent a promising therapeutic tool against liver injury and its associated hemostasis disturbances.…”
    Get full text
    Article
  12. 32
  13. 33
  14. 34

    Enhancing heart and circulatory well-being through optimized radial artery techniques: a meta-analysis of hemostasis and patient comfort by Yanru Yang, Hongyan Zhu, Guangyao Zai

    Published 2025-01-01
    “…This synthesis highlights the nuanced impact of air volume adjustments in transradial bands on patient outcomes, emphasizing the necessity for further research and standardized protocols to optimize patient safety and comfort post-intervention.ConclusionThe TR Band, when utilized with optimized air volume/pressure, maintains an essential balance between ensuring hemostasis and enhancing patient comfort without elevating the risk of radial artery complications. …”
    Get full text
    Article
  15. 35

    Analysis of the effect of initial hemostasis resuscitation with recombinant human coagulation factor VII a on the treatment of postoperative hemorrhage in cardiac surgery by Yan Yu, Maomao Liu, Xuran Lu, Li Yu, Nan Liu

    Published 2025-01-01
    “…Conclusion Initial hemostasis resuscitation can significantly reduce the bleeding volume and blood product requirements in patients with bleeding complications after cardiac surgery who were treated with rFVIIa, thus improving patient prognosis. …”
    Get full text
    Article
  16. 36

    Implementation of a Cost and Variation Reduction Program for Hemostasis Products at a Large Academic Medical Center: A Multi-Stakeholder Perspective by Shah T, Brethauer S, Danker III WA, Doshi I, O'Hara M, Silber A, Vasileff WK

    Published 2025-01-01
    “…Thus, we sought to evaluate hospital stakeholder satisfaction with conversion to a sole supplier for hemostasis products, in addition to economic and clinical impacts, to help develop best practices for implementation.Methods: This cross-sectional study assessed satisfaction with converting to a sole supplier for hemostasis products at a large US academic medical center using qualitative interviews and quantitative surveys with clinical and non-clinical stakeholders, on the decision-making process, conversion, and vendor-supported hemostasis optimization program (HOP) post-implementation (February 2022–May 2022). …”
    Get full text
    Article
  17. 37
  18. 38
  19. 39
  20. 40